Evidence map›Paper›PMID 31817084›Full record

ReviewMolecules (Basel, Switzerland)2019

Anti-Inflammatory and Anticancer Properties of Bioactive Compounds from

Ming-Shun Wu, Levent Bless B Aquino, Marjette Ylreb U Barbaza, Chieh-Lun Hsieh, Kathlia A De Castro-Cruz, Ling-Ling Yang, Po-Wei Tsai

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Principles and Therapeutics ofJournal of pharmacy & bioallied sciences · 2024
    Review
  14. Sesamol as a potent anticancer compound: from chemistry to cellular interactions.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  15. Article
  16. Article
  17. Efficacy and classification ofFrontiers in chemistry · 2024
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ming-Shun WuDivision of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan.
Levent Bless B AquinoSchool of Chemical, Biological, Materials Engineering and Sciences, Mapúa University, 1002 Metro Manila, Philippines.
Marjette Ylreb U BarbazaSchool of Chemical, Biological, Materials Engineering and Sciences, Mapúa University, 1002 Metro Manila, Philippines.
Chieh-Lun HsiehDepartment of Athletics Sports, College of Humanities and Social Sciences, Chang Jung Christian University, Tainan 711, Taiwan.
Kathlia A De Castro-CruzSchool of Chemical, Biological, Materials Engineering and Sciences, Mapúa University, 1002 Metro Manila, Philippines.
Ling-Ling YangSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
Po-Wei TsaiDepartment of Medical Sciences Industry, College of Health Sciences, Chang Jung Christian University, Tainan 711, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of foodstuff as natural medicines has already been established through studies demonstrating the pharmacological activities that they exhibit. Knowing the nutritional and pharmacological significance of foods enables the understanding of their role against several diseases. Among the foods that can potentially be considered as medicine, is sesame or

Indexed as

AnimalsAnti-Inflammatory AgentsAntineoplastic AgentsDisease Models, AnimalHumansLignansPhytochemicalsSesamumAnti-Inflammatory AgentsAntineoplastic AgentsLignansPhytochemicalsanti-canceranti-inflammatorysesame extractssesame oilSesamum indicum L.

Identifiers

PMID31817084
PMCPMC6943436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.